Introduction : Pharmaceutical Regulatory Services in India

Pharmaceutical companies seeking to promote their products in international markets must undertake one fundamental regulatory activity first: to comply with the regulations of that particular country.

Each country has its laws governing drug safety, quality, and compliance that must be satisfied before medicines can be manufactured, marketed, and sold in that country.

Failure to do so can build intractable, damaging barriers against a company, including product rejections, products being banned from markets, and a tarnished reputation that takes years to recover, if ever.

For pharmaceutical regulatory services in India, Actiza Pharmaceutical offers comprehensive and end-to-end services.

Being a drug regulatory affairs India company, we consider the biggest challenges of product regulators, exporters and owners and provide comprehensive solutions to product registrations in both semi-regulated and fully regulated markets of the world.

Our team works on the pharma regulatory support of your products so that you can focus on your business.

With over 550 dossiers and signatory presence across 40 countries and certified WHO-GMP, Actiza is a company that has a name in pharmaceutical regulatory services in India and global market support in regulatory compliance.

Talk to our regulatory team! Get a Free Consultation.

What Exactly Are Pharmaceutical Regulatory Services?

Legal conformity in a target market requires pharma regulatory support pertaining to the documentation, submissions, and approvals processes for the sale of a medical product in the market.

The absence of drug regulatory affairs in India may potentially result in product rejections, bans, and additional delays.

These scenarios could be equally detrimental in a treaty-governed country and in a lightly-regulated country.

The pharmaceutical industry generally comprises two distinct categories of country markets.

Regulated markets include the U.S., the E.U., the U.K. and Australia. In these markets, the unambiguous, delineated regulatory frameworks that span most of the globe require detailed regulatory submissions.

A second class of markets is the semi-regulated category that encompasses the majority of the countries of Africa, Southeast Asia, the countries of the Commonwealth of Independent States, the countries of the Middle East, and countries of Latin America.

In these markets, each country has its own unique regulatory submission requirements that must be thoroughly understood before filing.

We have practical experience in working with clients in both market categories and also provides pharmaceutical regulatory services in India.

Such services are critical to India-based pharma exporters and global pharma brands and include product registration in India and marketing authorization in India submissions across various countries. To understand how our manufacturing capabilities support this process, visit our Contract Manufacturing & Third Party Manufacturing page.

Regulatory Services We Offer at Actiza

This is what we are experts at. Our drug regulatory affairs India team engages in all phases starting from the approval process, from the preliminary documentation to the final documentation.

Below is the list of structures we provide.

Dossier Preparation- CTD, eCTD & ACTD Format

A regulatory dossier is a comprehensive technical pack that is submitted to a regulatory authority for approval of a product. Actiza does full dossier compilation under the CTD dossier preparation India pack.

Covers both the Common Technical Document (CTD) and eCTD (electronic CTD) submission in India formats that are favored by markets such as the US FDA, EMA, MHRA, TGA, and Health Canada.

For the ASEAN region, we prepare the ACTD format dossier. Country-specific formats for the rest of the world (ROW) markets are also supported by us.

We are the premier dossier preparation company in India. We promote improved and complete submissions.

Product Registration & Marketing Authorization

Product registration in India and other global markets is a stepwise process that needs careful registration and submission.

We offer full support from preparation to submission to the respective Ministry of Health, FDA, or any other regulatory entity.

Furthermore, marketing authorization in India submissions are handled by our team while we stay engaged in the process until we receive the registration certificate.

COPP & CPP Documentation

Certificate of Pharmaceutical Product (COPP or CPP) is an essential export documentation requirement by most importing countries.

COPP CPP documentation in India is a niche service we offer to exporters and manufacturers under regulated and semi-regulated markets.

Several markets will not even process a registration application in the absence of this document.

We offer the most accurate COPP and CPP documentation to assist your export goals.

Drug Master File (DMF) Preparation

A Drug Master File (DMF) includes the confidential technical documents on the API or the finished formulation.

Our service of DMF preparation in India covers both DMF preparation of API and of finished product, in open and closed part preparation, to fulfill the requirements of the target country.

This is extremely useful to API manufacturers, who are supplying to foreign markets, wherein the DMF is an essential part of the registration process.

Variations & Post-Approval Changes

The completion and approval of a regulatory application do not signal an end to the associated regulatory obligations.

Post-approval of any change to the submission in a product’s formulation, manufacturing location, packaging, and/or labels is termed a variation.

Our pharma regulatory support handles all the different types of Variations, namely Type Ia, Type Ib, and Type II.

Annual reports, along with renewals of Marketing Authorizations, are also taken care of to ensure that your regulatory approvals remain valid and legal in all the markets in which you are registered.

SmPCs, PILs, & Labelling Support

Product labelling and patient information are subject to strict regulations globally. .

As part of our pharmaceutical regulatory services in India, Actiza drafts and reviews the Summary of Product Characteristics (SmPC), Patient Information Leaflets(PILs), and labelling in compliance with the regulations.

We also change the existing product documentation when the law changes and a revision is necessary.

Regulatory Strategy & Consulting

Before any document is compiled, the optimal regulatory pathway must be ascertained.

Our regulatory consultant pharmaceutical India team offers country-specific advice on the ideal route to market, undertaking a gap analysis of the current documents, and recommending the quickest and least costly pathway to securing market authorization.

This strategic input eliminates the loss of resources through unnecessary mistakes or document restructuring before submission.

CTD, eCTD & ACTD – Which Dossier Format Does Your Market Require?

Choosing the correct dossier format is one of the most critical steps in the product registration process.

Different markets require different formats, and submitting the wrong format can lead to delays or outright rejection.

We have hands-on experience preparing dossiers in all three major formats – CTD, eCTD, and ACTD – based on the target market requirements of each client.

CTD – Common Technical Document

The Common Technical Document (CTD) is the globally accepted standard format for drug registration applications. It is organized into five modules, each covering a specific area of the submission:

Module 1: Administrative and regional information specific to the target country
Module 2: Summaries and overviews of quality, non-clinical, and clinical data
Module 3: Quality information covering chemistry, manufacturing, and controls (CMC)
Module 4: Non-clinical study reports including pharmacology and toxicology
Module 5: Clinical study reports and related information

CTD format is widely accepted across regulated and semi-regulated markets including the European Union, USA, UK, Australia, Canada, Japan, CIS countries, and Middle Eastern countries.

eCTD Electronic Common Technical Document

The eCTD is the electronic version of the CTD. It follows the same five-module structure but is submitted digitally through a structured lifecycle management system.

Several major regulatory authorities including the US FDA and the European Medicines Agency (EMA) now mandate eCTD format for all new submissions.

The electronic format allows regulatory agencies to review, track, and manage submissions more efficiently, which can result in faster processing times for applicants.

ACTD ASEAN Common Technical Document

The ACTD is a harmonized dossier format developed specifically for ASEAN member countries, including Vietnam, Thailand, Malaysia, Singapore, Indonesia, and the Philippines.

It is structured into four parts rather than five modules:

Part I – Administrative Documents
Part II – Quality Documents
Part III – Non-Clinical Study Reports
Part IV – Clinical Study Reports

The ACTD was developed because most ASEAN submissions are reference applications meaning the product has already been approved in another country.

As a result, the level of documentation required is generally lower than a full CTD submission, and complete clinical study reports are not always mandatory.

We prepare dossiers in CTD, eCTD, and ACTD formats, as well as country-specific formats for markets that follow their own local guidelines.

Our regulatory team advises each client on the correct format based on their target market before work begins.

Global Markets We Support for Regulatory Filing

Actiza offers pharma regulatory support services covering a variety of markets for a complete view of our global footprint, visit our Global Presence page.

Our team is familiar with specific country requirements for documentation, dossier preparation, and submission for each listed region.

Regulated Markets:

USA – US FDA
European Union – EMA
United Kingdom – MHRA
Australia – TGA
Canada – Health Canada

Semi-Regulated / ROW Markets:

Africa: pharmaceutical registration Africa including Nigeria, Kenya, Ghana, Tanzania, Ethiopia, etc.
Southeast Asia: Vietnam, Thailand, Malaysia, Philippines, Indonesia, for medicine registration Southeast Asia
CIS Countries: drug approval CIS countries, including Russia, Ukraine, Kazakhstan, Uzbekistan, Azerbaijan, etc.
Middle East: UAE, KSA, Jordan, Iraq, with dedicated pharma regulatory support in the Middle East
Latin America: country-specific formats in several markets

Our product registration India team brings the expertise and experience to properly guide complicated submissions.

We have substantial expertise in pharmaceutical registration in Africa, drug approval in CIS countries and Southeast Asia markets.

For an individual country or multi-member country product registration in India and other countries, you can rely on us.

Why Choose Actiza for Pharmaceutical Regulatory Services?

There are a number of providers for regulatory services pharmaceutical company India. Here are a few reasons for you to partner with us.

550+ Ready Dossiers:

We have a library of dossiers across product ranges. This gives you the flexibility of dependencies and time to market through quicker product registration in India.

WHO-GMP Certified Manufacturer:

Our WHO-GMP certification is accepted as the primary quality standard across regulated and semi-regulated markets, significantly streamlining the registration process, giving you an advantage in marketing authorization India.

In-house Drug Regulatory Affairs Team:

With extensive experience in both regulated and semi-regulated markets, our drug regulatory affairs India experts specialize. We assign specialists, not generalists, to every client engagement.

End-to-End Pharma Regulatory Support:

Our pharma regulatory support team takes full ownership, from the initial documentation all the way to the final registration certificate.

Multi-format Dossier Expertise:

As a seasoned dossier preparation company India, we cover all market needs through CTD, eCTD submission India, ACTD dossier, and country-specific submissions.

Manufacturer + Regulatory- One Partner:

Actiza unifies both spheres, as opposed to the extensive list of singular regulatory consultant pharmaceutical India.

Singular consulting puts us on the same level, facilitating the elimination of any and all coordination gaps, in addition to the minimization of all inconsistencies between the data and regulatory submissions.

Export Track Record in 40+ Countries:

Our proven experience in pharmaceutical registration Africa, drug approval CIS countries, the Middle East, and the rest of the regulated markets makes us an expert in pharmaceutical regulatory services India.

How Our Regulatory Support Process Works

The assurance we provide is a completed guide, from the initial step of the first query to the closing step of the registration.

Building on your specific needs, we frequently tailor our process.

Initial Consultation: We begin by understanding your product, target markets, current documentation status, and registration goals. This gives our drug regulatory affairs India team a clear picture of the scope of work ahead.
Regulatory Pathway Assessment: We determine the dossier format, regulatory authority, and submission specifications for your target country. Examples include guidelines on CTD dossier preparation India and formats for pharmaceutical registration Africa or drug approvals for CIS countries.
Gap Analysis: The regulatory consultant pharmaceutical India team examines your available documentation and highlights the gaps and redundancies, non-compliant, or misaligned data and format that could prolong the approval.
Dossier Compilation & Writing: Our regulatory team writes each module, and in CTD dossier preparation India, eCTD submission India, ACTD dossier, and ROW – and checks for accuracy, completion, and compliance.
Quality Review: Our pharma regulatory support team conducts an internal review of the complete dossier to mitigate concerns.
Submission to Regulatory Authority: We manage and control submission-related actions, product registration in India and marketing authorization India on your behalf, or partner in submission as your support.
Query Response & Follow-up: Our drug regulatory affairs India team accepts the continuous questions that regulatory authorities raise and conducts all necessary correspondence related to the settlement of the matter.
Receipt of Registration Certificate: We maintain support during all phases of the approval process and register the certificate.

Frequently Asked Questions – Pharmaceutical Regulatory Services

Q 1. What is a CTD dossier and why is it required?

A CTD dossier (Common Technical Document) compiles the scientific data on pharmaceutical products in a structure that is internationally recognized and required by most of the world’s pharmaceutical regulatory authorities.

CTD dossier preparation India is organized in five modules that separately contain the data on the quality, safety, and efficacy of the product.

Countries in most of the regulated markets including Canada, the UK, the EU, the US, and Australia, require the dossier to be prepared according to the specific guidelines of CTD for the purpose of supporting product registration and subsequent marketing authorization.

Q 2. Which dossier format is needed for African markets?

Within the African continent, the dossier requirements differ by country. Some countries require the CTD format while others require a specific country format.

Actiza has experience in pharmaceutical registration Africa markets including Nigeria, Kenya, Ghana, Tanzania, and Ethiopia. We ensure that the dossier is in a format that is compliant with the requirements of the specific regulatory authority.

Q 3. Can Actiza handle regulatory submissions for both APIs and finished formulations?

Yes, Actiza has the DMF preparation in India for both APIs and finished products. Our drug regulatory affairs India services are designed to assist you in preparing a full regulatory dossier for finished products as well as provide consultancy for API regulatory submissions in your target jurisdiction.

Q 4. How long does product registration typically take?

Regulated markets such as the US FDA and EU typically require 18–36 months.

Semi-regulated markets including CIS countries generally require 12–24 months. African markets typically range from 6–18 months.

Q 5. Do you provide regulatory support for products manufactured by other companies?

Yes, There are many ways to pharma regulatory support and backed with experience and effectiveness to prepare CTD India Operations, eCTD for India, and also ACTD.

Regulatory consultant pharmaceutical India is complemented by tutorials on COPP CPP documentation India, and full marketing authorization to and filing services for over 40 countries.

Get Regulatory Support for Your Pharmaceutical Products

Bringing a new pharmaceutical product to market is more than just having a quality product; it’s about having a specific, compliant, and market-targeted regulatory strategy.

With that, Actiza offers a range of pharmaceutical regulatory services.

Whether your requirements are CTD dossier preparation India, support for eCTD submission India, preparation of ACTD dossiers, or COPP CPP documentation India, as well as complete marketing authorization India, and filing in more than 40 countries, Actiza provides an all-in-one end-to-end service.

As a WHO-GMP certified manufacturer and a full-service drug regulatory affairs India team, we fill all gaps in coordination for you.

There is record accountability in the services we offer you from the first document we prepare until we receive final approvals.

Contact us today to get started. Call us | Email us | Fill in the contact form